EUVIMEDEUVIMED entdecken
Open Access

Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Elif O Dogan, Sean R Simonini, James Bouley, Alexandra Weiss, Robert H Brown iD, Nils Henninger iD

Annals of Neurology · 2025

DOI: 10.1002/ana.27174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Elif O Dogan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Armadillo Domain Proteins, Cytoskeletal Proteins, Superoxide Dismutase-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Moloney Fellowship, Angel Fund for ALS Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Approximately 20% of familial cases of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene encoding superoxide dismutase 1 (SOD1). Epidemiological data have identified traumatic brain injury (TBI) as an exogenous risk factor for ALS; however, the mechanisms by which TBI may worsen SOD1 ALS remain largely undefined.

Methods

We sought to determine whether repetitive TBI (rTBI) accelerates disease onset and progression in the transgenic SOD1 G93A mouse ALS model, and whether loss of the primary regulator of axonal degeneration sterile alpha and TIR motif containing 1 ( Sarm1 ) mitigates the histological and behavioral pathophysiology. We subjected wild‐type (n = 23), Sarm1 knockout (KO; n = 17), SOD1 G93A (n = 19), and SOD1 G93A xSarm1 KO (n = 26) mice of both sexes to rTBI or sham surgery at age 64 days (62–68 days). Body weight and ALS‐deficit score were serially assessed up to 17 weeks after surgery and histopathology assessed in layer V of the primary motor cortex at the study end point.

Results

In sham injured SOD1 G93A mice, genetic ablation of Sarm1 did not attenuate axonal loss, improve neurological deficits, or survival. The rTBI accelerated onset of G93A‐SOD1 ALS, as indicated by accentuated body weight loss, earlier onset of hindlimb tremor, and shortened survival. The rTBI also triggered TDP‐43 mislocalization, enhanced axonal and neuronal loss, microgliosis, and astrocytosis. Loss of Sarm1 significantly diminished the impact of rTBI on disease progression and rescued rTBI‐associated neuropathology.

Interpretation

SARM1‐mediated axonal death pathway promotes pathogenesis after TBI in SOD1 G93A mice suggesting that anti‐SARM1 therapeutics are a viable approach to preserve neurological function in injury‐accelerated G93A‐SOD1 ALS. ANN NEUROL 2025;97:963–975

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisArmadillo Domain ProteinsCytoskeletal ProteinsSuperoxide Dismutase-1Brain Injuries, TraumaticAnimalsMiceMice, TransgenicDisease Models, AnimalMaleFemaleMice, KnockoutDisease Progression

Substanzen

Armadillo Domain ProteinsSARM1 protein, mouseCytoskeletal ProteinsSuperoxide Dismutase-1

Autor:innen und Institutionen

  • Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA.
  • Department of Psychiatry, University of Massachusetts Chan Medical School, Worcester, MA.

ORCID-Profile: Robert H Brown, Nils Henninger

Förderung

  • NINDS NIH HHS
  • Moloney Fellowship
  • Angel Fund for ALS Research
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Dogan, E. O., Simonini, S. R., Bouley, J., Weiss, A., Brown, R. H., & Henninger, N. (2025). Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.27174

Vancouver

Dogan EO, Simonini SR, Bouley J, Weiss A, Brown RH, Henninger N. Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. Annals of Neurology. 2025. doi:10.1002/ana.27174

BibTeX
@article{Dogan2025,
  author = {Dogan, Elif O and Simonini, Sean R and Bouley, James and Weiss, Alexandra and Brown, Robert H and Henninger, Nils},
  title = {Genetic Ablation of Sarm1 Mitigates Disease Acceleration after Traumatic Brain Injury in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.27174}
}
Kostenlos starten →